Aptevo Therapeutics Inc (APVO)

Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	5.81%3.70	3.92	3.54	4.04	3.33
Research and Development	5.81%3.70	3.92	3.54	4.04	3.33
Operating Income/Loss	5.76%-6.44	-6.84	-6.00	-7.61	-6.23
Income/Loss From Continuing Operations After Tax	5.09%-6.36	-6.70	-	-7.55	-6.20
	5.09%-6.36	-6.70	-5.81	-7.55	-6.20
Attributable To Parent	5.09%-6.36	-6.70	-5.81	-7.55	-6.20
Available To Common Stockholders, Basic	6.45%-6.36	-6.79	-5.90	-9.03	-6.20
Basic Average Shares	12.79%1.20	1.06	-	4.05	0.74
Diluted Average Shares	12.79%1.20	1.06	-	4.05	0.74
Basic Earnings Per Share	17.16%-5.31	-6.41	-	-2.23	-8.40
Diluted Earnings Per Share	17.16%-5.31	-6.41	-	-2.23	-8.40